Raymond James analyst Michael Rose lowered the firm’s price target on Comerica to $53 from $57 and keeps a Strong Buy rating on the shares. The analyst adjusted estimates for banks ahead of the Q2 results, saying net interest margin pressure is likely to be greater than most expect. The “honeymoon” period of the tightening cycle, in which assets reprice higher while liabilities repricing lags, has come to an end, the analyst tells investors in a research note. The firm expects funding cost pressures will persist longer than most expect.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CMA: